These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 19718021)

  • 1. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor.
    Alvarado D; Klein DE; Lemmon MA
    Nature; 2009 Sep; 461(7261):287-91. PubMed ID: 19718021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single ligand is sufficient to activate EGFR dimers.
    Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argos inhibits epidermal growth factor receptor signalling by ligand sequestration.
    Klein DE; Nappi VM; Reeves GT; Shvartsman SY; Lemmon MA
    Nature; 2004 Aug; 430(7003):1040-4. PubMed ID: 15329724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for EGFR ligand sequestration by Argos.
    Klein DE; Stayrook SE; Shi F; Narayan K; Lemmon MA
    Nature; 2008 Jun; 453(7199):1271-5. PubMed ID: 18500331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.
    Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Kofler M; Jorissen RN; Nice EC; Burgess AW; Ward CW
    Mol Cell; 2003 Feb; 11(2):495-505. PubMed ID: 12620236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
    Macdonald-Obermann JL; Adak S; Landgraf R; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2013 Oct; 288(42):30773-30784. PubMed ID: 24014028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.
    Huang GC; Ouyang X; Epstein RJ
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):113-9. PubMed ID: 9512468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism.
    Fan YX; Wong L; Ding J; Spiridonov NA; Johnson RC; Johnson GR
    J Biol Chem; 2008 Jan; 283(3):1588-1596. PubMed ID: 18039657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic regulation and function of epidermal growth factor receptor signalling in patterning of the embryonic Drosophila brain.
    Jussen D; von Hilchen J; Urbach R
    Open Biol; 2016 Dec; 6(12):. PubMed ID: 27974623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.
    Reddy BV; Irvine KD
    Dev Cell; 2013 Mar; 24(5):459-71. PubMed ID: 23484853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.
    Choi BK; Fan X; Deng H; Zhang N; An Z
    Cancer Med; 2012 Aug; 1(1):28-38. PubMed ID: 23342251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
    Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
    Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix induced by steroids and aging through a G-protein-coupled receptor in a
    Zheng W; Ocorr K; Tatar M
    Dis Model Mech; 2020 Jun; 13(6):. PubMed ID: 32461236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
    Alvarado D; Klein DE; Lemmon MA
    Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
    Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
    J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
    Deb TB; Su L; Wong L; Bonvini E; Wells A; David M; Johnson GR
    J Biol Chem; 2001 May; 276(18):15554-60. PubMed ID: 11279155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.